Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extracellular acidity and increased exosome release as key phenotypes of malignant tumors
Mariantonia Logozzi, Enrico P. Spugnini, Davide Mizzoni, et al.
Cancer and Metastasis Reviews (2019) Vol. 38, Iss. 1-2, pp. 93-101
Closed Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Role of Glutathione in Cancer: From Mechanisms to Therapies
Luke Kennedy, Jagdeep K. Sandhu, Mary‐Ellen Harper, et al.
Biomolecules (2020) Vol. 10, Iss. 10, pp. 1429-1429
Open Access | Times Cited: 589
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf, Anamaria Brozović, Ana Cristina Gonçalves, et al.
Drug Resistance Updates (2019) Vol. 46, pp. 100645-100645
Closed Access | Times Cited: 438
Progress in Microfluidics‐Based Exosome Separation and Detection Technologies for Diagnostic Applications
Shujing Lin, Zixian Yu, Di Chen, et al.
Small (2019) Vol. 16, Iss. 9
Closed Access | Times Cited: 284
Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review)
Wararat Chiangjong, Somchai Chutipongtanate, Suradej Hongeng
International Journal of Oncology (2020) Vol. 57, Iss. 3, pp. 678-696
Open Access | Times Cited: 281
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Sabrina Dallavalle, Vladimir Dobričić, Loretta Lazzarato, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100682-100682
Open Access | Times Cited: 241
Using single-vesicle technologies to unravel the heterogeneity of extracellular vesicles
Guillermo Bordanaba-Florit, Félix Royo, Sergei G. Kruglik, et al.
Nature Protocols (2021) Vol. 16, Iss. 7, pp. 3163-3185
Open Access | Times Cited: 210
Role of Exosomes in Crosstalk Between Cancer-Associated Fibroblasts and Cancer Cells
Xi Yang, Yida Li, Liqing Zou, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 168
Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle
Xia Wang, Lü Tian, Jingyi Lu, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 155
Exosomes and breast cancer drug resistance
Xingli Dong, Xupeng Bai, Jie Ni, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 149
Boosting extracellular vesicle secretion
Lior Debbi, Shaowei Guo, Dina Safina, et al.
Biotechnology Advances (2022) Vol. 59, pp. 107983-107983
Open Access | Times Cited: 108
Small extracellular vesicles in cancer
Komal Abhange, Amy Makler, Yi Wen, et al.
Bioactive Materials (2021) Vol. 6, Iss. 11, pp. 3705-3743
Open Access | Times Cited: 104
Mesenchymal stem cell-derived exosomes: Characteristics and applications in disease pathology and management
Hafiza Padinharayil, Jinsu Varghese, Cornelia M. Wilson, et al.
Life Sciences (2024) Vol. 342, pp. 122542-122542
Closed Access | Times Cited: 18
Exosomes in Cancer: Diagnostic and Therapeutic Applications
Quratulain Maqsood, Aleena Sumrin, Yasar Saleem, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access | Times Cited: 17
Exosomes: Isolation, characterization, and biomedical applications
Ghadi N. Alzhrani, Sarah T. Alanazi, Sumayyah Yasser Alsharif, et al.
Cell Biology International (2021) Vol. 45, Iss. 9, pp. 1807-1831
Closed Access | Times Cited: 99
Exosomal biomarkers for cancer diagnosis and patient monitoring
Amy Makler, Waseem Asghar
Expert Review of Molecular Diagnostics (2020) Vol. 20, Iss. 4, pp. 387-400
Open Access | Times Cited: 98
Trends in Research on Exosomes in Cancer Progression and Anticancer Therapy
Dona Sinha, Sraddhya Roy, Priyanka Saha, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 326-326
Open Access | Times Cited: 90
Tumor Exosomes Reprogrammed by Low pH Are Efficient Targeting Vehicles for Smart Drug Delivery and Personalized Therapy against their Homologous Tumor
Changguo Gong, Xiao Zhang, Min Shi, et al.
Advanced Science (2021) Vol. 8, Iss. 10
Open Access | Times Cited: 83
Immunocapture-based ELISA to characterize and quantify exosomes in both cell culture supernatants and body fluids
Mariantonia Logozzi, Rossella Di Raimo, Davide Mizzoni, et al.
Methods in enzymology on CD-ROM/Methods in enzymology (2020), pp. 155-180
Open Access | Times Cited: 79
Quantitative Mapping of Glutathione within Intracranial Tumors through Interlocked MRI Signals of a Responsive Nanoprobe
Peisen Zhang, Jianfeng Zeng, Yingying Li, et al.
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 15, pp. 8130-8138
Closed Access | Times Cited: 72
Potential roles and prognostic significance of exosomes in cancer drug resistance
Mostafa Mostafazadeh, Nasser Samadi, Houman Kahroba, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 69
The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells
Cristina P. R. Xavier, Dimas Carolina Belisario, Rita Rebelo, et al.
Drug Resistance Updates (2022) Vol. 62, pp. 100833-100833
Open Access | Times Cited: 60
The translational paradigm of nanobiomaterials: Biological chemistry to modern applications
Adrija Sinha, Faizan Zarreen Simnani, Dibyangshee Singh, et al.
Materials Today Bio (2022) Vol. 17, pp. 100463-100463
Open Access | Times Cited: 59
Progress in the research of nanomaterial-based exosome bioanalysis and exosome-based nanomaterials tumor therapy
Zhiwei Sun, Jingjing Yang, Hui Li, et al.
Biomaterials (2021) Vol. 274, pp. 120873-120873
Closed Access | Times Cited: 57
The Potentiality of Plant-Derived Nanovesicles in Human Health—A Comparison with Human Exosomes and Artificial Nanoparticles
Mariantonia Logozzi, Rossella Di Raimo, Davide Mizzoni, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4919-4919
Open Access | Times Cited: 42
Insights into tumor-derived exosome inhibition in cancer therapy
Ziwei Tang, Cheng Chen, Chen Zhou, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117278-117278
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top